Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Caplyta (lumateperone)
.
Show all posts
Showing posts with label
Caplyta (lumateperone)
.
Show all posts
Monday, February 16, 2026
FDA Approves Caplyta (lumateperone) as an Adjunctive Therapy for the Treatment of Major Depressive Disorder (MDD) in Adults
›
In continuation of my update on lumateperone Johnson & Johnson (NYSE: JNJ) announced the U.S. Food and Drug Administration (FDA) approva...
Friday, February 14, 2020
FDA Approves Caplyta (lumateperone) for the Treatment of Schizophrenia in Adults
›
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous...
›
Home
View web version
